Biomarker testing for patients with ovarian cancer should be completed both in the upfront setting and through disease ...

The FDA has approved a biosimilar of pertuzumab which is indicated for multiple breast cancer settings. The FDA has approved ...

JADPRO Live 2025 provides a platform for leaders in oncology advanced practice to share research and best practices with ...

Nurse-led telehealth follow-ups may increase emotional well-being for survivors of ovarian cancer, according to data from a ...

Integrative oncology is a patient-centered approach to cancer care that looks at the whole patient and combines their ...

Panelists discuss how patients beginning talquetamab should maintain a positive attitude, prepare thoroughly with educational ...

Panelists discuss how effective caregivers should join support groups, maintain detailed records of symptoms and medications, ...

Panelists discuss how caregivers can navigate the initial shock of a myeloma diagnosis by seeking reliable information from ...

Panelists discuss how Alan Plisskin's multiple myeloma diagnosis began with severe back and hip pain, progressed through life ...

Panelists discuss how patients can maintain nutrition during talquetamab treatment by focusing on texture and food ...

Panelists discuss how successful talquetamab treatment requires coordinated care between inpatient and outpatient teams, ...

Panelists discuss how comprehensive patient education materials and manufacturer resources help patients prepare for and ...